DOCTEUR CAROLINE COLINET : médecine générale
0563.507.642 · rovalta.com · 27/09/2026
DOCTEUR CAROLINE COLINET : médecine générale
Financial year 2025 · Closed on 31/08/2025
Overview
Identity
Source · BCE/KBODOCTEUR CAROLINE COLINET : médecine générale is a Private limited company incorporated in 2014. Its registered office is in Schaerbeek.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0563.507.642
- Incorporation
- 01/10/2014
- Legal form
- Private limited company
- Registered office
- Rue Van Hammée 69
1030 Schaerbeek · BruxellesSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/08/2025
Financials
Source · NBB, 11 filingsTrend over 11 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 130,4 k € | -7.4% | 140,7 k € | +26.4% | 111,3 k € | -6.9% | 119,6 k € | – | |
| EBITDA | 101,4 k € | -4.2% | 105,9 k € | +63.8% | 64,6 k € | -16.2% | 77,1 k € | +7.6% | 71,7 k € |
| Operating result | 100,5 k € | -4.3% | 105 k € | +64.7% | 63,8 k € | -16.4% | 76,2 k € | +7.6% | 70,9 k € |
| Net result | 84,6 k € | -2.8% | 87 k € | +67.0% | 52,1 k € | -16.0% | 62 k € | +14.4% | 54,2 k € |
| Balance sheet | |||||||||
| Equity | 103,9 k € | 0.0% | 103,9 k € | -30.2% | 148,8 k € | -23.2% | 193,8 k € | +1.1% | 191,8 k € |
| Total assets | 195,6 k € | -21.6% | 249,6 k € | -0.3% | 250,2 k € | +0.1% | 250,1 k € | +26.8% | 197,3 k € |
| Cash | 44,5 k € | -73.9% | 170,1 k € | +134% | 72,6 k € | -60.2% | 182,4 k € | +28.7% | 141,7 k € |
| Debts | 91,7 k € | -37.0% | 145,7 k € | +43.6% | 101,5 k € | +80.2% | 56,3 k € | +917% | 5,5 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/08/20251 active · 1 ended
Active mandates
Ended mandates
Other companies at this address
Rue Van Hammée 69 1030 Schaerbeek| Company | CBE no. |
|---|---|
Fonds Médico Social ICB● Active | 0409.383.451 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/09/2024 | 01/09/2023 | 01/09/2022 | 01/09/2021 | 01/09/2020 | 01/09/2019 |
| Closing of the financial year | 31/08/2025 | 31/08/2024 | 31/08/2023 | 31/08/2022 | 31/08/2021 | 31/08/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 30/04/2026 | 30/04/2025 | 30/04/2024 | 30/04/2023 | 02/05/2022 | 06/04/2021 |
| General meeting | 19/02/2026 | 13/02/2025 | 15/02/2024 | 16/02/2023 | 17/02/2022 | 18/02/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 11 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/08/2025 | 19/02/2026 | 30/04/2026 | French | |
| Micro model | 31/08/2024 | 13/02/2025 | 30/04/2025 | French | |
| Micro model | 31/08/2023 | 15/02/2024 | 30/04/2024 | French | |
| Micro model | 31/08/2022 | 16/02/2023 | 30/04/2023 | French | |
| Micro model | 31/08/2021 | 17/02/2022 | 02/05/2022 | French | |
| Micro model | 31/08/2020 | 18/02/2021 | 06/04/2021 | French | |
| Micro model | 31/08/2019 | 20/02/2020 | 30/04/2020 | French | |
| Micro model | 31/08/2018 | 21/02/2019 | 30/04/2019 | French | |
| Micro model | 31/08/2017 | 15/02/2018 | 01/05/2018 | French | |
| Abridged model | 31/08/2016 | 23/02/2017 | 30/04/2017 | French | |
| Abridged model | 31/08/2015 | 25/02/2016 | 31/05/2016 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/08/20251 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202584,6 k €↓
- 2024Annual accounts 202487 k €↑
- 2023Annual accounts 202352,1 k €↓
- 2023Name changeDOCTEUR CAROLINE COLINET : médecine géné
- 2022Annual accounts 202262 k €↑
- 2022Name changeDOCTEUR CAROLINE COLINET
- 2021Annual accounts 202154,2 k €↑
- 2021Name changeDOCTEUR CAROLINE COLINET : médecine générale
- 2020Annual accounts 202045,4 k €↓
- 2019Annual accounts 201956,9 k €↑
- 2018Annual accounts 201855 k €↑
- 2017Annual accounts 201748,5 k €↑
- 2016Annual accounts 201615,8 k €↑
- 2015Annual accounts 20154,8 k €
- 01/10/2014IncorporationPrivate limited company